Jazz Pharmaceuticals plc

US$234.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:JAZZHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 7.91%
Div yield —
ROE 5.05%
Biotechnology
Beta (5Y) 0.37
PE TTM 75.77
TSR TTM 70.56%
Mkt cap US$15.07B
ROIC 14.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$250
6.56%
(67.27%)
Hold 11|5|8|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
3.05
3.08
3.31
3.15
31.05%
21.68%
19.03%
14.22%
Revenue$B
1.647
1.684
1.699
1.755
(1.96%)
(2.74%)
0.19%
5.42%
Peers (US$15.07B)
Cap (US$)
PE
7.713B
—
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
5.428
(0.523)
(0.379)
EBIT/Intx
0.433
0.869
0.896
Own earn%
(20.00)
10.16
13.32
Sh yield%
26.78
18.98
19.56
Owners
Insiders/Inst%
10.01
76.53
Short interest%
2.31
SBC / revenue%
1.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
8